BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11318154)

  • 41. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sample-size redetermination for repeated measures studies.
    Zucker DM; Denne J
    Biometrics; 2002 Sep; 58(3):548-59. PubMed ID: 12229989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coupled error spending functions for parallel bivariate sequential tests.
    Cook RJ
    Biometrics; 1996 Jun; 52(2):442-50. PubMed ID: 8672698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statistical inference following sample size adjustment based on the 50%-conditional-power principle.
    Chen YHJ; Yuan SS; Li X
    J Biopharm Stat; 2018; 28(3):575-587. PubMed ID: 28850000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adaptive sample size calculations in group sequential trials.
    Lehmacher W; Wassmer G
    Biometrics; 1999 Dec; 55(4):1286-90. PubMed ID: 11315085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Robustness of sample size re-estimation procedure in clinical trials (arbitrary populations).
    Govindarajulu Z
    Stat Med; 2003 Jun; 22(11):1819-28. PubMed ID: 12754717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Internal pilots for observational studies.
    Gurka MJ; Coffey CS; Gurka KK
    Biom J; 2010 Oct; 52(5):590-603. PubMed ID: 20857422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing frequency of interim analysis in sequential monitoring.
    Lan KK; DeMets DL
    Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exact statistical inference for group sequential trials.
    Lin DY; Wei LJ; DeMets DL
    Biometrics; 1991 Dec; 47(4):1399-408. PubMed ID: 1786325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A boundary-optimized rejection region test for the two-sample binomial problem.
    Gabriel EE; Nason M; Fay MP; Follmann DA
    Stat Med; 2018 Mar; 37(7):1047-1058. PubMed ID: 29280170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive vs. group sequential self-designing trials.
    Mehrotra DV; Fan X
    Biom J; 2006 Aug; 48(4):710-2; discussion 713. PubMed ID: 16972723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interim treatment selection using the normal approximation approach in clinical trials.
    Shun Z; Lan KK; Soo Y
    Stat Med; 2008 Feb; 27(4):597-618. PubMed ID: 17619239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sample size re-estimation: recent developments and practical considerations.
    Gould AL
    Stat Med; 2001 Sep 15-30; 20(17-18):2625-43. PubMed ID: 11523073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeated confidence intervals in self-designing clinical trials and switching between noninferiority and superiority.
    Hartung J; Knapp G
    Biom J; 2006 Aug; 48(4):697-709. PubMed ID: 16972722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tests for homogeneity of the risk difference when data are sparse.
    Lipsitz SR; Dear KB; Laird NM; Molenberghs G
    Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.